A panel session with CEOs from Stryker, Tawuniya, Lean and NUPCO outlined how AI and predictive analytics are driving personalised, proactive care, while cross-sector collaboration and clear governance are proving essential to achieving Vision 2030 goals. Saudi Arabia has already reduced mortality from non-communicable diseases by 40% and is advancing towards its target of 80 years life expectancy. This comes as Saudi Arabia transitions to a value-based healthcare model, anchored in outcomes, data transparency and population health.
Fahad Al-Shebel, CEO of NUPCO, said: “We're delighted to return to the Global Health Exhibition after a successful experience last year. The event provides NUPCO with a critical platform to showcase our ongoing efforts to enhance healthcare supply chains through innovation, efficiency, and digital transformation in line with Vision 2030."
This year’s exhibition features the strongest line-up of global healthcare giants to date, including GE, Siemens Healthineers, Fujifilm, Johnson & Johnson, GSK, Samsung, Danaher, Karl Storz and Stryker. Saudi Arabia’s leading healthcare organisations will also be present, such as Health Holding, NUPCO, Saudi Commission for Health Specialties, Dallah Health, HAYAT National Hospitals, Lean and STC, and Diamond Partners, including Tawuniya and WuXi AppTec. In addition, Hayat National Hospitals unveiled four strategic investments totalling 7 billion SAR - focused on hospital expansion and medical centre development, service expansion, human capital and smart infrastructure. Dr Fouziyah Aljarallah, CEO of Hayat National Hospitals said: "Our vision is to transform healthcare delivery in Saudi Arabia. We are committed to advancing medical excellence, supporting our workforce and integrating smart technologies that will redefine patient care. Saudi Arabia is poised to become a global reference point for health innovation, and we are proud to be part of that journey."